Meet the current Society board

Executive Positions

Ann HoffmanPresident
Ann was elected as president of the society in 2020. She has been a pivotal member of the council and society for several years and is currently an investigator at GSK invloved in High Content Imaging and Drug Design and Selection.

Investigator
GlaxoSmithKline
Collegeville, PA

Debra NickischerSecretary
Debby was elected Secretary Elect of SBI2 in 2019 and moved to Secretary in 2020. Debby has been heavily involved in the board and society for several years. She is currently a Research Scientist at Arvinas using her 20 years of high content imaging experience to help with Lead Discovery efforts.

Arvinas
New Haven, CT

Jeff HaskinsTreasurer
Jeff is currently an Executive Director of Global In Vitro Toxicology at Charles River Laboratories. He has over 30 years experience in cellular imaging and toxicology. Jeff was previously a senior research associate at Pfizer in the Discovery Toxicology Group and R&D Director at Thermo Fisher Scientific.

Executive Director, Global In Vitro Toxicology
Charles River Laboratories, Cleveland, OH

Myles FennelPast President
Myles is the past president of the society from 2018 to 2019

Council

Beth Cimini
Broad Institute
Ty Voss
National Institutes of Health
Shannon Mumenthaler
University of Southern California
Judi Wardwell
In Sphero
Neil Carragher
The University of
Edinburgh
David Gebhard
David Gebhard LLC
Todd Shelper
Griffith University
 
Bartek Rajwa
Purdue University
Santosh Hariharan
Pfizer
Chandima Bandaranayaka
Photon Biosciences, LLC

Committees 

Standards

Michael Halter
Julie Li
Thierry Dorval
Liz Rubitski
Steve Titus

Publications

Kaylene Simpson
Myles Fennell

Jeff Haskins
Todd Shelper
Steve Titus

Educational committee

Bartek Rajwa
Dave Gebhardt
Debby Nickisher

Marketing and Vendor Communications

Justin Boyd
Judi Wardwell
Debby Nickisher
Mike Mancini

Bylaws

Steve Titus
Steve Haney
Jeff Haskins
Myles Fennell
Joe Trask
Ann Hoffman